Evolent Health (NYSE:EVH) Stock Price Breaks Below Fifty Day Moving Average – Should You Sell?

Posted by George Bondi on Sep 26th, 2026

Evolent Health, Inc (NYSE:EVH – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $4.21 and traded as low as $3.51. Evolent Health shares last traded at $3.5150, with a volume of 1,894,636 shares traded.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. Citigroup upgraded Evolent Health from a “neutral” rating to a “buy” rating and cut their target price for the company from $6.75 to $6.00 in a research note on Monday, August 10th. Weiss Ratings downgraded shares of Evolent Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, September 14th. TD Cowen boosted their price objective on shares of Evolent Health from $5.00 to $6.00 and gave the stock a “buy” rating in a research report on Monday, August 17th. JPMorgan Chase & Co. increased their target price on shares of Evolent Health from $5.00 to $6.00 and gave the stock an “overweight” rating in a report on Tuesday, August 18th. Finally, Truist Financial lowered their price target on shares of Evolent Health from $7.00 to $6.00 and set a “hold” rating on the stock in a research note on Wednesday, August 12th. Eleven research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $5.96.

Check Out Our Latest Stock Report on Evolent Health

Evolent Health Stock Performance

The firm has a market capitalization of $405.77 million, a price-to-earnings ratio of -0.79 and a beta of 0.84. The stock’s fifty day moving average is $4.16 and its two-hundred day moving average is $3.98. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 2.52.

Evolent Health (NYSE:EVH – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The technology company reported $0.02 EPS for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.03. Evolent Health had a negative net margin of 24.08% and a negative return on equity of 4.27%. The firm had revenue of $484.50 million during the quarter, compared to analysts’ expectations of $597.70 million. During the same quarter last year, the company posted ($0.10) earnings per share. The company’s revenue for the quarter was up 46.9% compared to the same quarter last year. On average, analysts predict that Evolent Health, Inc will post -0.25 earnings per share for the current year.

Insider Buying and Selling

In related news, President Daniel Mccarthy sold 65,892 shares of Evolent Health stock in a transaction dated Wednesday, August 26th. The stock was sold at an average price of $5.00, for a total transaction of $329,460.00. Following the completion of the transaction, the president owned 655,133 shares in the company, valued at approximately $3,275,665. This trade represents a 9.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.48% of the company’s stock.

Institutional Trading of Evolent Health

A number of hedge funds have recently made changes to their positions in the business. Maverick Capital Ltd. increased its holdings in shares of Evolent Health by 1.3% during the 1st quarter. Maverick Capital Ltd. now owns 2,572,763 shares of the technology company’s stock worth $5,866,000 after acquiring an additional 32,833 shares during the last quarter. Castle Hook Partners LP bought a new stake in Evolent Health in the 4th quarter valued at $3,751,000. Public Employees Retirement System of Ohio acquired a new stake in Evolent Health during the 2nd quarter valued at $760,000. Sei Investments Co. lifted its holdings in Evolent Health by 50.8% during the 1st quarter. Sei Investments Co. now owns 302,281 shares of the technology company’s stock valued at $689,000 after purchasing an additional 101,867 shares during the last quarter. Finally, First Trust Advisors LP bought a new position in Evolent Health during the first quarter worth $488,000.

Evolent Health Company Profile

(Get Free Report)

Evolent Health, Inc (NYSE: EVH) is a healthcare technology and services company focused on helping health plans and healthcare providers transition to value-based care. Its platform and services are designed to support the management of patient populations, improve clinical outcomes, and align healthcare payments with the quality and cost effectiveness of care.

The company provides solutions that may include specialty care management, population health management, administrative services, payment integrity, clinical decision support, and technology for coordinating care.